On Wednesday, March 25, 2026, the Haitian National Police (PNH) presented a summary of the results of operations and interventions carried out during the first quarter of 2026. A total of 32 ...

EMPAVELI (pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in Canada Approval supported by Phase 3 52-week VALIANT study demonstrated reduced ...

EMPAVELI®(pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in CanadaApproval supported ...

At week 25, participants in the COMMODORE 2 trial continuing crovalimab therapy had fatigue scores similar to those of the general population. Findings from the phase 3 COMMODORE 1 and 2 clinical ...

Most of us think of cars as a huge purchase. A reliable new vehicle can cost anywhere from $25,000 to $32,000. But what if a single dose of medicine costs even more than that? That's exactly the ...

TANGO2 deficiency disorder (TDD) is a rare autosomal recessive condition characterized by neurodevelopmental impairment and recurrent metabolic crises. Paroxysmal non-epileptic neurological episodes ( ...

The company's asset-to-be has two commercialized medicines on the market based on the same active ingredient.

Bringing together Biogen and Apellis’ commercialization capabilities will maximize the potential of both EMPAVELI ® and SYFOVRE ®, while Apellis’ talent and expertise will accelerate Biogen’s entry ...

On Monday, March 23, 2026, at the National Police Academy (ANP), as part of the decentralization policy for issuing police certificates, implemented by the Central Directorate of the Judicial Police ...